IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MANCUSO, MARIA ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.329
NA - Nord America 1.546
AS - Asia 596
SA - Sud America 26
Continente sconosciuto - Info sul continente non disponibili 10
AF - Africa 8
OC - Oceania 2
Totale 4.517
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.511
GB - Regno Unito 933
DE - Germania 432
SE - Svezia 359
CN - Cina 346
IT - Italia 211
UA - Ucraina 76
IN - India 72
IE - Irlanda 68
TR - Turchia 53
FI - Finlandia 51
KR - Corea 47
EU - Europa 42
FR - Francia 41
NL - Olanda 33
RU - Federazione Russa 33
DK - Danimarca 31
CA - Canada 27
BE - Belgio 23
SG - Singapore 23
CO - Colombia 19
HK - Hong Kong 13
JP - Giappone 12
IR - Iran 10
GR - Grecia 8
ID - Indonesia 8
MX - Messico 8
CH - Svizzera 6
RO - Romania 6
BR - Brasile 5
NO - Norvegia 5
AT - Austria 4
ZA - Sudafrica 4
EG - Egitto 3
ES - Italia 3
AU - Australia 2
CL - Cile 2
MY - Malesia 2
PL - Polonia 2
PT - Portogallo 2
QA - Qatar 2
TW - Taiwan 2
BY - Bielorussia 1
CY - Cipro 1
HU - Ungheria 1
IL - Israele 1
MA - Marocco 1
OM - Oman 1
PK - Pakistan 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 4.549
Salva come PNG Salva come JPEG
Città #
Southend 837
Hanover 240
Chandler 179
Houston 143
Seattle 105
Milan 99
Princeton 89
Ann Arbor 82
Wilmington 78
Fairfield 74
Ashburn 70
Beijing 69
Dublin 68
Woodbridge 54
Dearborn 46
Frankfurt am Main 45
Jacksonville 45
Nanjing 34
Des Moines 31
Redmond 31
Bengaluru 29
Boardman 28
Mountain View 28
Redwood City 28
Somerville 26
Cambridge 25
Jinan 23
Helsinki 22
Serra 21
Shenyang 21
Andover 20
Margão 20
Bogotá 19
Sakarya 19
Hangzhou 17
Berlin 16
Shanghai 16
Brussels 15
Nanchang 15
Phoenix 15
Toronto 15
Hebei 14
Tianjin 14
Changsha 12
Fuzhou 12
New York 12
Roxbury 12
Saint Petersburg 12
Guangzhou 11
Munich 10
Ottawa 10
Hong Kong 8
London 8
Silver Spring 8
Taizhou 8
Athens 7
Duncan 6
Eitensheim 6
San Diego 6
Amsterdam 5
Antwerpen 5
Bitonto 5
Fremont 5
Istanbul 5
Kunming 5
Ningbo 5
Pisa 5
Atlanta 4
Grafing 4
Haikou 4
Hamburg 4
Iowa City 4
Medford 4
Singapore 4
Washington 4
Wuhan 4
Bangalore 3
Columbus 3
Jiaxing 3
Kenilworth 3
Mexico 3
Pars 3
Rotterdam 3
São Paulo 3
Tehran 3
Verona 3
Xian 3
Zhengzhou 3
Auburn Hills 2
Aurora 2
Bergamo 2
Bolzano 2
Boston 2
Bristol 2
Bühl 2
Carol Stream 2
Central District 2
Changchun 2
Chengdu 2
Lanzhou 2
Totale 3.169
Salva come PNG Salva come JPEG
Nome #
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A 518
Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients 385
Cognitive and psychological profiles in treatment compliance: a study in an elderly population with hemophilia 209
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease 152
Circulating endothelial cells (CECs) and progenitors (CEPs) in severe haemophiliacs with different clinical phenotype 143
Absence of association between erythropoietin gene variation and ALS in sporadic Italian patients. 141
A recurrent F8 mutation (c.6046C>T) causing hemophilia A in 8% of northern Italian patients : evidence for a founder effect 131
Association study between XRCC1 gene polymorphisms and sporadic amyotrophic lateral sclerosis 128
The natural history of hepatitis C virus infection in Italian patients with von Willebrand's disease : A cohort study 126
Immune tolerance induction with recombinant factor VIII in hemophilia A patients with high responding inhibitors 123
Mutational Repertoire in the SIPPET Cohort and Prediction of FVIII Inhibitor Risk 123
The Influence of F8 Mutation and Thrombophilic Genetic Markers on Bleeding Phenotype of Patients Affected with Severe Hemophilia A in the SIPPET Cohort 121
Solvent/detergent plasma for prevention of bleeding in recessively inherited coagulation disorders : dosing, pharmacokinetics and clinical efficacy 120
Rescue FVIII replacement to secure haemostasis in a patient with haemophilia A and inhibitors on emicizumab prophylaxis undergoing hip replacement 120
High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C 117
Involvement of the IgE-basophil system and mild complement activation in haemophilia B with anti-factor IX neutralizing antibodies and anaphylaxis 114
Environmental risk factors for inhibitor development in children with haemophilia A : a case-control study 112
Sequential combined bypassing therapy : a rescue option in refractory bleeds – the Italian experience 111
Progranulin genotyping in 237 sporadic amyothropic lateral sclerosis patients 110
Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII : considerations on the differentiation between the 2 circulating anticoagulants 109
Severe hemophilia with mild bleeding phenotype : molecular characterization and global coagulation profile 108
Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters 107
A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors 107
Low-rate of complications after a long-term use of ateriovenous fistula (AVF) in hemophilic children 106
Factors influencing the long-term outcome of primary total knee replacement in haemophiliacs : a review of 116 procedures at a single institution 103
Increased thrombin generation in severe hemophiliacs with mild clinical phenotype 102
Interferon lambda 3 rs12979860 polymorphism in patients with haemophilia and HCV infection : a predictor of spontaneous viral clearance and sustained virological response 99
Fatigue and exercise intolerance in mitochondrial diseases. Literature revision and experience of the Italian Network of mitochondrial diseases 96
Platelets from glioblastoma patients promote angiogenesis of tumor endothelial cells and exhibit increased VEGF content and release 91
Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors 85
Ageing successfully with haemophilia : A multidisciplinary programme 81
Applying a deliberation model to the analysis of consultations in haemophilia: Implications for doctor-patient communication 81
Integrated postural analysis in children with haemophilia 77
Type and intensity of FVIII exposure on inhibitor development in PUPs with haemophilia A : a patient-level meta-analysis 72
Sequential combined bypassing therapy is safe and effective in the treatment of unresponsive bleeding in adults and children with haemophilia and inhibitors 64
X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers 58
Handwriting Analysis in Children and Adolescents with Hemophilia : A Pilot Study 52
Polypharmacy in older adults with severe haemophilia 46
Evaluation of an automated chromogenic assay for Factor VIII clotting activity measurement in patients affected by haemophilia A 45
Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management 35
null 5
Totale 4.833
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.320
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.320
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019135 0 0 0 0 0 0 0 0 0 0 45 90
2019/2020805 108 15 35 55 76 107 70 39 139 106 32 23
2020/2021568 39 52 53 28 61 47 45 31 56 43 85 28
2021/2022708 63 19 20 67 52 66 68 48 63 82 56 104
2022/2023712 112 102 56 67 76 131 6 60 70 3 19 10
2023/2024263 11 34 15 33 88 21 18 11 9 22 1 0
Totale 4.833